Ireland
--:--IST
Recruiting Not applicable

Role of Exercise in PRISm and Subsequent Development of COPD

NCT07387432 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2025-07-14
Last updated
2026-03-06

Condition(s) studied

Preserved Ratio Impaired Spirometry (PRISM)

Investigational drug(s) / intervention(s)

Exercise with telehealth groupExercise groupNo exercise group

Exercise with telehealth group: Participants will attend telehealth physiotherapy class for exercise. Smoking cessation advice will be given.

Exercise group: Participants will exercise with walking. Smoking cessation advice will be given.

No exercise group: No exercise instruction will be given. Participants are encouraged to exercise. Smoking cessation advice will be given.

Study summary

Preserved Ratio Impaired Spirometry (PRISm) describes individual with spirometry findings of forced expiratory volume (FEV1) and forced vital capacity (FVC) ratio greater than 0.7 but with the FEV1 less than 80% predicted.

While the spirometry findings of individuals with PRISm can be transited into obstructive pattern, remains at PRISm or become normal spirometry, limited evidence is on the role of exercise in the course of PRISm. This study aims to investigate the role of exercise, namely exercise with telehealth and walking exercise, together with smoking cessation advice, would alter the clinical course of PRISm.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 or above * Smoker/ ex-smoker * Spirometry shows PRISm, with FEV1/FVC \>= 0.7 and FEV1 \<80% predicted * Ambulatory to walk * Able to give informed consent Exclusion Criteria: * Age below 18 * Non-smoker * Spirometry does not show PRISm/ unable to perform spirometry * Requires assistance for walking * Unable to give informed consent

Primary outcome measure(s)

  • Change in 6 minute walk test distance — 1 year
    The 6 minute walk test distance will be measured in the start of the study, at 3 months, 6 months and 12 months. The differences will be compared.

Trial sites (1)

FacilityCityRegionStatus
The University of Hong Kong, Queen Mary Hospital Hong Kong China Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07387432 on ClinicalTrials.gov ↗ ← All trials in China